Table 3 Comparison of clinical outcomes in patient with complex coronary lesions.

From: Outcomes of early versus delayed invasive strategy in older adults with non-ST-segment elevation myocardial infarction

Outcomes

Early invasive (n = 897)

Delayed invasive (n = 386)

Log-rank

Unadjusted

p

Multivariable-adjusteda

p

HR (95% CI)

HR (95% CI)

MACCE

221 (24.6)

99 (25.6)

0.725

0.958 (0.756–1.215)

0.726

1.034 (0.810–1.320)

0.787

All-cause death

127 (14.2)

56 (14.5)

0.849

0.970 (0.708–1.328)

0.849

1.047 (0.755–1.452)

0.783

Cardiac death

69 (7.8)

32 (8.3)

0.707

0.923 (0.607–1.403)

0.707

1.139 (0.735–1.765)

0.561

Non-cardiac death

58 (6.4)

24 (6.2)

0.895

1.032 (0.642–1.661)

0.895

1.081 (0.661–1.768)

0.758

Recurrent MI

37 (4.4)

16 (4.5)

0.974

0.990 (0.551–1.780)

0.974

1.159 (0.634–2.119)

0.631

Any repeat revascularization

79 (9.6)

36 (10.3)

0.772

0.943 (0.636–1.399)

0.772

1.050 (0.701–1.572)

0.814

Stroke

27 (3.2)

16 (4.6)

0.294

0.719 (0.387–1.335)

0.296

1.216 (0.640–2.312)

0.550

ST (definite or probable)

4 (0.5)

3 (0.9)

0.454

0.596 (0.127–2.542)

0.460

2.662 (0.531–13.35)

0.234

  1. MACCE major adverse cardiac and cerebrovascular events, ST stent thrombosis, HR hazard ratio, CI confidence interval, LVEF left ventricular ejection fraction, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, DM diabetes mellitus, PCI percutaneous coronary intervention, CK-MB creatine kinase myocardial band, eGFR estimated glomerular filtration rate, HDL high-density lipoprotein, GRACE Global Registry of Acute Coronary Events. aAdjusted by male sex, age, LVEF, BMI, SBP, DBP, cardiogenic shock, symptom-to-door time, hypertension, DM, dyslipidemia, previous MI and PCI, current smoker, peak CK-MB, peak troponin-I, serum creatinine, eGFR < 60 mL/min/1.73 m2, HDL-cholesterol, and GRACE risk score > 140.
Back to article page